Combination for the treatment of alcohol and drug dependence containing an opioid antagonist and a NMDA receptor complex modulator
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Jan 28, 2003
Grant Date -
N/A
app pub date -
Jan 12, 2001
filing date -
Mar 26, 1998
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
A pharmaceutical composition for the treatment of alcohol and drug dependence, comprising a therapeutically effective amount of a combination of: (i) an opioid antagonist; and (ii) a NMDA receptor complex modulator. A pharmaceutical kit is also provided, comprising these two substances. The opioid antagonist can, for example, be naltrexone and the NMDA receptor complex modulator can be a spermidine site modulator such as acamprosate.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully